Spain fines pharmaceuticals cartel €5.8 million
Spain's antitrust enforcer has fined the country's only two suppliers of drugs used in nuclear medicine – including a local Novartis subsidiary – for dividing the market and rigging tenders.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.